Compare Stocks: ARAY, RMTI, ABT, and SYK

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$105.99 +0.3%	$93.45	$81.97 ▼ $137.49	$183.40B	0.59	12.75 million shs	9.61 million shs
ARAY Accuray	$0.27	$0.30	$0.22 ▼ $2.10	$31.89M	1.39	1.54 million shs	1.88 million shs
RMTI Rockwell Medical	$7.19	$6.47	$4.89 ▼ $21.00	$28.54M	1.6	33,888 shs	18,087 shs
SYK Stryker	$326.41 +0.2%	$317.28	$281.00 ▼ $401.99	$125.13B	0.76	2.48 million shs	4.54 million shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	0.00%	+2.77%	+11.27%	+18.40%	-16.76%
ARAY Accuray	0.00%	+12.46%	+5.18%	-42.55%	-79.05%
RMTI Rockwell Medical	0.00%	+8.45%	+29.78%	-19.05%	-24.78%
SYK Stryker	0.00%	-1.30%	+0.00%	+10.48%	-13.79%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$105.99 +0.3%	$93.45	$81.97 ▼ $137.49	$183.40B	0.59	12.75 million shs	9.61 million shs
ARAY Accuray	$0.27	$0.30	$0.22 ▼ $2.10	$31.89M	1.39	1.54 million shs	1.88 million shs
RMTI Rockwell Medical	$7.19	$6.47	$4.89 ▼ $21.00	$28.54M	1.6	33,888 shs	18,087 shs
SYK Stryker	$326.41 +0.2%	$317.28	$281.00 ▼ $401.99	$125.13B	0.76	2.48 million shs	4.54 million shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	0.00%	+2.77%	+11.27%	+18.40%	-16.76%
ARAY Accuray	0.00%	+12.46%	+5.18%	-42.55%	-79.05%
RMTI Rockwell Medical	0.00%	+8.45%	+29.78%	-19.05%	-24.78%
SYK Stryker	0.00%	-1.30%	+0.00%	+10.48%	-13.79%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.92	Moderate Buy	$118.17	11.50% Upside
ARAY Accuray	1.67	Reduce	$2.00	645.99% Upside
RMTI Rockwell Medical	2.00	Hold	$20.00	178.16% Upside
SYK Stryker	2.83	Moderate Buy	$387.88	18.83% Upside

Current Analyst Ratings Breakdown

Latest ARAY, RMTI, ABT, and SYK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	SYK Stryker	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/31/2026	SYK Stryker	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$435.00 ➝ $420.00
7/31/2026	SYK Stryker	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$370.00
7/31/2026	SYK Stryker	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$420.00 ➝ $390.00
7/31/2026	SYK Stryker	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$375.00
7/31/2026	SYK Stryker	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$400.00 ➝ $350.00
7/31/2026	SYK Stryker	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$330.00 ➝ $340.00
7/31/2026	SYK Stryker	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$371.00 ➝ $358.00
7/28/2026	SYK Stryker	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$400.00
7/28/2026	ABT Abbott Laboratories	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$135.00 ➝ $125.00
7/28/2026	SYK Stryker	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral ➝ Buy	$400.00

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$44.33B	4.14	$7.01 per share	15.12	$30.35 per share	3.49
ARAY Accuray	$458.51M	0.07	$0.04 per share	6.01	$0.72 per share	0.37
RMTI Rockwell Medical	$69.26M	0.41	N/A	N/A	$9.38 per share	0.77
SYK Stryker	$25.12B	4.98	$16.93 per share	19.28	$58.63 per share	5.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$6.52B	$3.09	34.30	17.43	2.05	11.65%	17.69%	9.44%	10/21/2026 (Estimated)
ARAY Accuray	-$1.59M	-$0.37	N/A	N/A	N/A	-10.76%	-79.43%	-10.38%	8/12/2026 (Estimated)
RMTI Rockwell Medical	-$5.31M	-$1.50	N/A	16.72	N/A	-7.98%	-15.41%	-9.62%	8/13/2026 (Estimated)
SYK Stryker	$3.25B	$9.65	33.82	19.67	2.08	14.43%	23.63%	11.39%	N/A

Latest ARAY, RMTI, ABT, and SYK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	RMTI Rockwell Medical	-$0.2350	N/A	N/A	N/A	$17.82 million	N/A
8/12/2026	Q4 2026	ARAY Accuray	-$0.03	N/A	N/A	N/A	$105.30 million	N/A
7/30/2026	Q2 2026	SYK Stryker	$3.49	$3.69	+$0.20	$3.30	$6.58 billion	$6.59 billion
7/16/2026	Q2 2026	ABT Abbott Laboratories	$1.28	$1.31	+$0.03	$0.53	$12.52 billion	$12.59 billion
5/7/2026	Q1 2026	RMTI Rockwell Medical	-$0.10	-$0.40	-$0.30	-$0.04	$17.95 million	$17.34 million
5/6/2026	Q3 2026	ARAY Accuray	-$0.05	-$0.09	-$0.04	-$0.09	$111.90 million	$104.85 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.52	2.38%	+10.39%	81.55%	54 Years
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
RMTI Rockwell Medical	N/A	N/A	N/A	N/A	N/A
SYK Stryker	$3.52	1.08%	+7.58%	36.48%	32 Years

Latest ARAY, RMTI, ABT, and SYK Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/12/2026	ABT Abbott Laboratories	quarterly	$0.63	2.82%	7/15/2026	7/15/2026	8/17/2026
5/6/2026	SYK Stryker	quarterly	$0.88	1.12%	6/30/2026	6/30/2026	7/31/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.57	1.38	0.97
ARAY Accuray	3.21	1.42	0.66
RMTI Rockwell Medical	0.23	3.74	3.43
SYK Stryker	0.59	2.16	1.33

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
ARAY Accuray	64.08%
RMTI Rockwell Medical	23.31%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
ARAY Accuray	4.36%
RMTI Rockwell Medical	4.60%
SYK Stryker	4.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.73 billion	1.72 billion	Optionable
ARAY Accuray	1,040	118.96 million	113.78 million	Optionable
RMTI Rockwell Medical	300	3.97 million	3.78 million	Optionable
SYK Stryker	56,000	383.36 million	365.73 million	Optionable

ARAY, RMTI, ABT, and SYK Headlines

Recent News About These Companies

Rathbones Group PLC Boosts Position in Stryker Corporation $SYK

2 hours ago | marketbeat.com

Stryker (NYSE:SYK) Price Target Raised to $340.00

August 3 at 2:12 AM | americanbankingnews.com

JPMorgan Chase & Co. Cuts Stryker (NYSE:SYK) Price Target to $350.00

August 3 at 2:12 AM | americanbankingnews.com

BTIG Research Cuts Stryker (NYSE:SYK) Price Target to $358.00

August 3 at 2:12 AM | americanbankingnews.com

Promising Medical Stocks To Follow Today - August 2nd

August 2 at 2:00 PM | marketbeat.com

Stryker: Analyst Sees Share Weakness as a Chance to Buy into a Durable High-Growth Medtech Leader

August 2 at 7:11 AM | tipranks.com

15,653 Shares in Stryker Corporation $SYK Bought by First Nebraska Trust Co

August 2 at 4:15 AM | marketbeat.com

Stryker (NYSE:SYK) Stock Price Down 7.5% on Analyst Downgrade

August 2 at 1:21 AM | americanbankingnews.com

Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?

August 1 at 12:16 AM | ca.finance.yahoo.com

SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion

August 1 at 2:07 PM | finance.yahoo.com

How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors

August 1 at 2:07 PM | nz.finance.yahoo.com

Promising Medical Stocks To Add to Your Watchlist - August 1st

August 1 at 2:00 PM | marketbeat.com

Segall Bryant & Hamill LLC Has $22.91 Million Stake in Stryker Corporation $SYK

August 1 at 6:47 AM | marketbeat.com

Stryker Corporation $SYK Shares Sold by Compass Capital Management Inc.

August 1 at 4:47 AM | marketbeat.com

Edgestream Partners L.P. Cuts Position in Stryker Corporation $SYK

August 1 at 4:39 AM | marketbeat.com

Stryker Q2 Earnings Call Highlights

July 31 at 11:02 PM | marketbeat.com

JPMorgan Chase & Co. Has Lowered Expectations for Stryker (NYSE:SYK) Stock Price

July 31 at 2:41 PM | marketbeat.com

Why Stryker (SYK) Stock Is Falling Today

July 31 at 1:50 PM | quiverquant.comQ

Stryker (SYK) Q2 2026 Earnings

July 31 at 12:57 PM | 247wallst.com

Stryker: Q2 Earnings Snapshot

July 31 at 12:57 PM | chron.com

Stryker Corp. stock outperforms competitors despite losses on the day

July 31 at 12:57 PM | marketwatch.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ARAY, RMTI, ABT, and SYK Company Descriptions

Abbott Laboratories NYSE:ABT

$105.99 +0.29 (+0.27%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$105.62 -0.36 (-0.34%)

As of 07/31/2026 07:52 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Accuray NASDAQ:ARAY

$0.27 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.26 -0.01 (-2.65%)

As of 07/31/2026 07:59 PM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Rockwell Medical NASDAQ:RMTI

$7.19 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$7.19 0.00 (0.00%)

As of 07/31/2026 07:34 PM Eastern

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Stryker NYSE:SYK

$326.41 +0.71 (+0.22%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$325.84 -0.57 (-0.17%)

As of 07/31/2026 07:59 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, RMTI, ABT, and SYK Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, RMTI, ABT, and SYK Earnings

Compare Dividends

Latest ARAY, RMTI, ABT, and SYK Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, RMTI, ABT, and SYK Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ARAY, RMTI, ABT, and SYK Company Descriptions

Abbott Laboratories NYSE:ABT

Accuray NASDAQ:ARAY

Rockwell Medical NASDAQ:RMTI

Stryker NYSE:SYK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools